mortality/aging
• shorter median life span of 24 weeks
• mice treated with IS70, a recombinant AAV serotype 1 cassette with Sirt7 gene expression driven by a synthetic ICAM2 promoter show an expansion of median life span by 76%, from 25 to more than 44 weeks
|
• mice show accelerated aging in various tissues/organs
• mice treated with IS70 ameliorates aging features
|
growth/size/body
weight loss
(
J:287256
)
• mice exhibit weight loss
• mice treated with IS70 show a slight rescue in body weight loss
|
behavior/neurological
• running endurance is compromised
|
cardiovascular system
• severe fibrosis in the arteries
|
• intima-media thickening
|
• atherosclerosis is prominent, with aorta atheromatous plaque seen in all mice examined
|
• loss of CD31+ endothelial cells
|
• limb perfusion after ischemia is blunted; defect in blood flow recovery is due to an impaired ability to form new blood vessels in the ischemic region indicating defective neovascularization
|
• severe fibrosis in the heart
|
• heart/body weight ratio is increased, indicating dilated cardiomyopathy
|
• cardiac output is reduced in 7-8 month old mice
|
• left ventricular ejection fraction and fractional shortening are reduced in 7-8 month old mice
|
• heart rate is reduced in 7-8 month old mice
|
• acetylcholine-induced thoracic aorta relaxation is compromised
|
homeostasis/metabolism
• running endurance is compromised
|
muscle
• heart/body weight ratio is increased, indicating dilated cardiomyopathy
|
• left ventricular ejection fraction and fractional shortening are reduced in 7-8 month old mice
|
• acetylcholine-induced thoracic aorta relaxation is compromised
|
skeleton
• decrease in trabecular bone volume/tissue volume
|
• increase in trabecular separation
|
osteoporosis
(
J:287256
)
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
progeria | DOID:3911 |
OMIM:176670 |
J:287256 |